{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:26:46Z","timestamp":1793788006411,"version":"4.6.1"},"reference-count":257,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12223-026-01441-1","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:43:19Z","timestamp":1773380599000},"page":"1059-1094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic insights and emerging applications of human metapneumovirus (HMPV) treatment: From molecular design to translational immunity"],"prefix":"10.1007","volume":"71","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aldulaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayma Salim","family":"Waleed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbulakshmi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kavitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafid Jihad","family":"Albadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmal","family":"Abilkasimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutabar","family":"Latipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Smerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"1441_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s44162-025-00079-w","volume":"4","author":"KA Adedokun","year":"2025","unstructured":"Adedokun KA et al (2025) Rising global threat of human metapneumovirus (hMPV in 2024\/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics. J Rare Dis 4:16","journal-title":"J Rare Dis"},{"key":"1441_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/puh2.70094","volume":"4","author":"VA Adepoju","year":"2025","unstructured":"Adepoju VA, Adnani QES, Jamil S, Mohammadnezhad M, Abdulrahim A (2025) Global burden of human metapneumovirus: bridging gaps in prevention, diagnostics and treatment. Public Health Chall 4:e70094. https:\/\/doi.org\/10.1002\/puh2.70094","journal-title":"Public Health Chall"},{"key":"1441_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s13721-025-00674-3","volume":"15","author":"A Alishvandi","year":"2026","unstructured":"Alishvandi A, Aram C, Barancheshemeh M, Shekari T, Firuzpour F, Yazdi MH (2026) In silico design of a multi-epitope vaccine against NSCLC targeting T-cell exhaustion and metastasis: insights from RNA-seq and molecular dynamics simulation analysis. Network Modeling Analysis in Health Informatics and Bioinformatics 15:34. https:\/\/doi.org\/10.1007\/s13721-025-00674-3","journal-title":"Network Modeling Analysis in Health Informatics and Bioinformatics"},{"key":"1441_CR4","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.2174\/1381612827666210716160030","volume":"27","author":"K Alshaghdali","year":"2021","unstructured":"Alshaghdali K, Saeed M, Kamal MA, Saeed A (2021) Interaction of ectodomain of respiratory syncytial virus G protein with TLR2\/ TLR6 heterodimer: an in vitro and in silico approach to decipher the role of RSV G protein in pro-inflammatory response against the virus. Curr Pharm Des 27:4464\u20134476. https:\/\/doi.org\/10.2174\/1381612827666210716160030","journal-title":"Curr Pharm Des"},{"key":"1441_CR5","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1016\/j.vaccine.2012.09.018","volume":"30","author":"CS Ambrose","year":"2012","unstructured":"Ambrose CS, Wu X, Jones T, Mallory RM (2012) The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 30:6794\u20136801. https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.018","journal-title":"Vaccine"},{"key":"1441_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa2209367","volume":"387","author":"EJ Anderson","year":"2022","unstructured":"Anderson EJ et al (2022) Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age. N Engl J Med 387:1673\u20131687. https:\/\/doi.org\/10.1056\/NEJMoa2209367","journal-title":"N Engl J Med"},{"key":"1441_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11421-1","author":"C Aram","year":"2025","unstructured":"Aram C et al (2025a) Exploration of the protein and Pharmacological landscape of Monkeypox virus treatment: from entry point to end point. Mol Diversity. https:\/\/doi.org\/10.1007\/s11030-025-11421-1","journal-title":"Mol Diversity"},{"key":"1441_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025b.145203","volume":"318","author":"C Aram","year":"2025","unstructured":"Aram C, Firuzpour F, Barancheshmeh M, Kamali MJ (2025bb) Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: a review. Int J Biol Macromol 318:145203. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025b.145203","journal-title":"Int J Biol Macromol"},{"key":"1441_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07433-4","volume":"15","author":"C Aram","year":"2025","unstructured":"Aram C, Karami L, Ranjbar MM (2025c) Development of a candidate mRNA vaccine based on multi-peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach. Sci Rep 15:22610. https:\/\/doi.org\/10.1038\/s41598-025-07433-4","journal-title":"Sci Rep"},{"key":"1441_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac206","volume":"9","author":"A August","year":"2022","unstructured":"August A et al (2022) Safety and immunogenicity of an mRNA-based human metapneumovirus and parainfluenza virus type 3 combined vaccine in healthy adults. Open Forum Infect Dis 9:ofac206. https:\/\/doi.org\/10.1093\/ofid\/ofac206","journal-title":"Open Forum Infect Dis"},{"key":"1441_CR11","doi-asserted-by":"publisher","first-page":"e17818","DOI":"10.1371\/journal.pone.0017818","volume":"6","author":"A Bagnaud-Baule","year":"2011","unstructured":"Bagnaud-Baule A et al (2011) The human metapneumovirus matrix protein stimulates the inflammatory immune response in vitro. PLoS ONE 6:e17818","journal-title":"PLoS ONE"},{"key":"1441_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50659-5","volume":"15","author":"MJG Bakkers","year":"2024","unstructured":"Bakkers MJG et al (2024) Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer. Nat Commun 15:6270. https:\/\/doi.org\/10.1038\/s41467-024-50659-5","journal-title":"Nat Commun"},{"key":"1441_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1128\/jvi.01213-12","volume":"87","author":"MDR Ba\u00f1os-Lara","year":"2013","unstructured":"Ba\u00f1os-Lara MDR, Ghosh A, Guerrero-Plata A (2013) Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J Virol 87:1242\u20131251. https:\/\/doi.org\/10.1128\/jvi.01213-12","journal-title":"J Virol"},{"key":"1441_CR14","doi-asserted-by":"publisher","first-page":"8224","DOI":"10.1128\/jvi.02584-07","volume":"82","author":"X Bao","year":"2008","unstructured":"Bao X, Kolli D, Liu T, Shan Y, Garofalo RP, Casola A (2008) Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J Virol 82:8224\u20138229. https:\/\/doi.org\/10.1128\/jvi.02584-07","journal-title":"J Virol"},{"key":"1441_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062568","volume":"8","author":"X Bao","year":"2013","unstructured":"Bao X, Kolli D, Ren J, Liu T, Garofalo RP, Casola A (2013) Human metapneumovirus glycoprotein G disrupts mitochondrial signaling in airway epithelial cells. PLOS ONE 8:e62568. https:\/\/doi.org\/10.1371\/journal.pone.0062568","journal-title":"PLOS ONE"},{"key":"1441_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0168-1702(03)00065-0","volume":"93","author":"N Bastien","year":"2003","unstructured":"Bastien N et al (2003) Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res 93:51\u201362. https:\/\/doi.org\/10.1016\/s0168-1702(03)00065-0","journal-title":"Virus Res"},{"key":"1441_CR17","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1128\/jcm.42.8.3532-3537.2004","volume":"42","author":"N Bastien","year":"2004","unstructured":"Bastien N, Liu L, Ward D, Taylor T, Li Y (2004) Genetic variability of the G glycoprotein gene of human metapneumovirus. J Clin Microbiol 42:3532\u20133537. https:\/\/doi.org\/10.1128\/jcm.42.8.3532-3537.2004","journal-title":"J Clin Microbiol"},{"key":"1441_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/v16071087","volume":"16","author":"HC Bergeron","year":"2024","unstructured":"Bergeron HC, Crabtree J, Nagy T, Martin DE, Tripp RA (2024a) Probenecid inhibits human metapneumovirus (HMPV) replication in vitro and in BALB\/c mice. Viruses 16:1087","journal-title":"Viruses"},{"key":"1441_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/v16071087","author":"HC Bergeron","year":"2024","unstructured":"Bergeron HC, Crabtree J, Nagy T, Martin DE, Tripp RA (2024b) Probenecid inhibits human metapneumovirus (HMPV) replication in vitro and in BALB\/c mice. Viruses. https:\/\/doi.org\/10.3390\/v16071087","journal-title":"Viruses"},{"key":"1441_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/0-387-24180-9_4","volume":"560","author":"B Beutler","year":"2005","unstructured":"Beutler B, Hoebe K, Georgel P, Tabeta K, Du X (2005) Genetic analysis of innate immunity: identification and function of the TIR adapter proteins. Adv Exp Med Biol 560:29\u201339. https:\/\/doi.org\/10.1007\/0-387-24180-9_4","journal-title":"Adv Exp Med Biol"},{"key":"1441_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0042-6822(03)00528-2","volume":"315","author":"S Biacchesi","year":"2003","unstructured":"Biacchesi S et al (2003) Genetic diversity between human metapneumovirus subgroups. Virology 315:1\u20139. https:\/\/doi.org\/10.1016\/s0042-6822(03)00528-2","journal-title":"Virology"},{"key":"1441_CR22","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1128\/jvi.78.23.12877-12887.2004","volume":"78","author":"S Biacchesi","year":"2004","unstructured":"Biacchesi S et al (2004) Recombinant human metapneumovirus lacking the small hydrophobic SH and\/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78:12877\u201312887. https:\/\/doi.org\/10.1128\/jvi.78.23.12877-12887.2004","journal-title":"J Virol"},{"key":"1441_CR23","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.1128\/jvi.79.19.12608-12613.2005","volume":"79","author":"S Biacchesi","year":"2005","unstructured":"Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ (2005) Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79:12608\u201312613. https:\/\/doi.org\/10.1128\/jvi.79.19.12608-12613.2005","journal-title":"J Virol"},{"key":"1441_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12038-008-0067-y","volume":"33","author":"S Broor","year":"2008","unstructured":"Broor S, Bharaj P, Chahar HS (2008) Human metapneumovirus: a new respiratory pathogen. J Biosci 33:483\u2013493. https:\/\/doi.org\/10.1007\/s12038-008-0067-y","journal-title":"J Biosci"},{"key":"1441_CR25","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1128\/jvi.79.11.6588-6597.2005","volume":"79","author":"UJ Buchholz","year":"2005","unstructured":"Buchholz UJ et al (2005) Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol 79:6588\u20136597. https:\/\/doi.org\/10.1128\/jvi.79.11.6588-6597.2005","journal-title":"J Virol"},{"key":"1441_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36459-3","volume":"14","author":"M Cab\u00e1n","year":"2023","unstructured":"Cab\u00e1n M et al (2023) Cross-protective antibodies against common endemic respiratory viruses. Nat Commun 14:798","journal-title":"Nat Commun"},{"key":"1441_CR27","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1128\/jvi.03488-14","volume":"89","author":"H Cai","year":"2015","unstructured":"Cai H, Zhang Y, Ma Y, Sun J, Liang X, Li J (2015) Zinc binding activity of human metapneumovirus M2-1 protein is indispensable for viral replication and pathogenesis in vivo. J Virol 89:6391\u20136405. https:\/\/doi.org\/10.1128\/jvi.03488-14","journal-title":"J Virol"},{"key":"1441_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/pathogens4030682","volume":"4","author":"NR Cheemarla","year":"2015","unstructured":"Cheemarla NR, Guerrero-Plata A (2015) Immune response to human metapneumovirus infection: what we have learned from the mouse model. Pathogens 4:682\u2013696","journal-title":"Pathogens"},{"key":"1441_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.virol.2009.11.042","volume":"398","author":"D Chen","year":"2010","unstructured":"Chen D et al (2010) HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens. Virology 398:68\u201378. https:\/\/doi.org\/10.1016\/j.virol.2009.11.042","journal-title":"Virology"},{"key":"1441_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.virol.2016.09.026","volume":"499","author":"Y Chen","year":"2016","unstructured":"Chen Y et al (2016) Functional motifs responsible for human metapneumovirus M2-2-mediated innate immune evasion. Virology 499:361\u2013368. https:\/\/doi.org\/10.1016\/j.virol.2016.09.026","journal-title":"Virology"},{"key":"1441_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwac104","volume":"9","author":"Z Chen","year":"2022","unstructured":"Chen Z et al (2022) A CRISPR\/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2. Natl Sci Rev 9:nwac104. https:\/\/doi.org\/10.1093\/nsr\/nwac104","journal-title":"Natl Sci Rev"},{"key":"1441_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85259","volume":"17","author":"N Chittiprol","year":"2025","unstructured":"Chittiprol N et al (2025) The re-emergence of human metapneumovirus: virus classification, characteristics, mechanisms of infection, clinical features, diagnosis, epidemiology, prevention, and treatment. Cureus 17:e85259. https:\/\/doi.org\/10.7759\/cureus.85259","journal-title":"Cureus"},{"key":"1441_CR33","doi-asserted-by":"publisher","first-page":"1012873","DOI":"10.3389\/fmicb.2022.1012873","volume":"13","author":"T Chongyu","year":"2022","unstructured":"Chongyu T et al (2022) A chimeric influenza virus vaccine expressing fusion protein epitopes induces protection from human metapneumovirus challenge in mice. Front Microbiol 13:1012873. https:\/\/doi.org\/10.3389\/fmicb.2022.1012873","journal-title":"Front Microbiol"},{"key":"1441_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101190","author":"C Chupin","year":"2021","unstructured":"Chupin C et al (2021) Avian cell line DuckCelt(\u00ae)-T17 is an efficient production system for live-attenuated human metapneumovirus vaccine candidate Metavac(\u00ae). Vaccines. https:\/\/doi.org\/10.3390\/vaccines9101190","journal-title":"Vaccines"},{"issue":"Pt 4","key":"1441_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1099\/0022-1317-73-4-849","volume":"73","author":"PL Collins","year":"1992","unstructured":"Collins PL, Mottet G (1992) Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of Brefeldin A. J Gen Virol 73(Pt 4):849\u2013863. https:\/\/doi.org\/10.1099\/0022-1317-73-4-849","journal-title":"J Gen Virol"},{"key":"1441_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1128\/JVI.75.3.1117-1123.2001","volume":"75","author":"EC Coronel","year":"2001","unstructured":"Coronel EC, Takimoto T, Murti KG, Varich N, Portner A (2001) Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J Virol 75:1117\u20131123","journal-title":"J Virol"},{"key":"1441_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature12442","volume":"501","author":"D Corti","year":"2013","unstructured":"Corti D et al (2013) Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature 501:439\u2013443. https:\/\/doi.org\/10.1038\/nature12442","journal-title":"Nature"},{"key":"1441_CR38","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1128\/JVI.01133-12","volume":"86","author":"RG Cox","year":"2012","unstructured":"Cox RG, Livesay SB, Johnson M, Ohi MD, Williams JV (2012) The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins. J Virol 86:12148\u201312160","journal-title":"J Virol"},{"key":"1441_CR39","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1128\/jvi.00332-14","volume":"88","author":"RG Cox","year":"2014","unstructured":"Cox RG et al (2014) Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model. J Virol 88:6368\u20136379. https:\/\/doi.org\/10.1128\/jvi.00332-14","journal-title":"J Virol"},{"key":"1441_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.0801433106","volume":"106","author":"G Cseke","year":"2009","unstructured":"Cseke G et al (2009a) Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci U S A 106:1566\u20131571. https:\/\/doi.org\/10.1073\/pnas.0801433106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1441_CR41","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.0801433106","volume":"106","author":"G Cseke","year":"2009","unstructured":"Cseke G et al (2009b) Integrin \u03b1v\u03b21 promotes infection by human metapneumovirus. Proc Natl Acad Sci USA 106:1566\u20131571","journal-title":"Proc Natl Acad Sci USA"},{"key":"1441_CR42","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1073\/pnas.1808849116","volume":"116","author":"JG Cullen","year":"2019","unstructured":"Cullen JG et al (2019) CD4(+) T help promotes influenza virus-specific CD8(+) T cell memory by limiting metabolic dysfunction. Proc Natl Acad Sci USA 116:4481\u20134488. https:\/\/doi.org\/10.1073\/pnas.1808849116","journal-title":"Proc Natl Acad Sci USA"},{"key":"1441_CR43","doi-asserted-by":"publisher","first-page":"e0169924","DOI":"10.1128\/jvi.01699-24","volume":"98","author":"W Dai","year":"2024","unstructured":"Dai W et al (2024) Lipid nanoparticles as adjuvant of Norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway. J Virol 98:e0169924. https:\/\/doi.org\/10.1128\/jvi.01699-24","journal-title":"J Virol"},{"key":"1441_CR44","doi-asserted-by":"publisher","unstructured":"De Arcos-Jim\u00e9nez JC, Martinez-Ayala P, Quintero-Salgado E, Lopez-Romo R, Briseno-Ramirez J (2025) Trends of respiratory viruses and factors associated with severe acute respiratory infection in patients presenting at a university hospital: a 6-year retrospective study across the COVID-19 pandemic. Front Public Health Volume 13\u20132025. https:\/\/doi.org\/10.3389\/fpubh.2025.1494463","DOI":"10.3389\/fpubh.2025.1494463"},{"key":"1441_CR45","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1099\/vir.0.83537-0","volume":"89","author":"M de Graaf","year":"2008","unstructured":"de Graaf M et al (2008) Specificity and functional interaction of the polymerase complex proteins of human and avian metapneumoviruses. J Gen Virol 89:975\u2013983. https:\/\/doi.org\/10.1099\/vir.0.83537-0","journal-title":"J Gen Virol"},{"key":"1441_CR46","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1099\/vir.0.009688-0","volume":"90","author":"M de Graaf","year":"2009","unstructured":"de Graaf M, Schrauwen EJA, Herfst S, van Amerongen G, Osterhaus A, Fouchier RAM (2009) Fusion protein is the main determinant of metapneumovirus host tropism. J Gen Virol 90:1408\u20131416. https:\/\/doi.org\/10.1099\/vir.0.009688-0","journal-title":"J Gen Virol"},{"key":"1441_CR47","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/cid\/ciab969","volume":"74","author":"A de Zwart","year":"2022","unstructured":"de Zwart A et al (2022) Respiratory syncytial virus, human Metapneumovirus, and parainfluenza virus infections in lung transplant recipients: A systematic review of outcomes and treatment strategies. Clin Infect Dis 74:2252\u20132260. https:\/\/doi.org\/10.1093\/cid\/ciab969","journal-title":"Clin Infect Dis"},{"key":"1441_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1177\/135965350801300603","volume":"13","author":"C Deffrasnes","year":"2008","unstructured":"Deffrasnes C et al (2008a) Inhibition of human metapneumovirus replication by small interfering RNA. Antivir Ther 13:821\u2013832","journal-title":"Antivir Ther"},{"key":"1441_CR49","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/aac.00793-07","volume":"52","author":"C Deffrasnes","year":"2008","unstructured":"Deffrasnes C, Hamelin M-\u00c8, Prince Gregory A, Boivin G (2008b) Identification and Evaluation of a Highly Effective Fusion Inhibitor for Human Metapneumovirus. Antimicrob Agents Chemother 52:279\u2013287. https:\/\/doi.org\/10.1128\/aac.00793-07","journal-title":"Antimicrob Agents Chemother"},{"key":"1441_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/aac.00793-07","volume":"52","author":"C Deffrasnes","year":"2008","unstructured":"Deffrasnes C, Hamelin ME, Prince GA, Boivin G (2008c) Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrob Agents Chemother 52:279\u2013287. https:\/\/doi.org\/10.1128\/aac.00793-07","journal-title":"Antimicrob Agents Chemother"},{"key":"1441_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/AAC.00793-07","volume":"52","author":"M-E Deffrasnes Cl, Hamelin","year":"2008","unstructured":"Deffrasnes Cl, Hamelin M-E, Prince GA, Boivin G (2008d) Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrob Agents Chemother 52:279\u2013287","journal-title":"Antimicrob Agents Chemother"},{"key":"1441_CR52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14027","volume":"173","author":"FL Dignan","year":"2016","unstructured":"Dignan FL et al (2016) BCSH\/BSBMT\/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. Br J Haematol 173:380\u2013393. https:\/\/doi.org\/10.1111\/bjh.14027","journal-title":"Br J Haematol"},{"key":"1441_CR53","doi-asserted-by":"crossref","unstructured":"Dixit A et al (2023) Interim safety and immunogenicity of COVID-19 Omicron-BA. 1 Variant-containing vaccine in children. MedRxiv 20232006. 2023.23291767","DOI":"10.1101\/2023.06.23.23291767"},{"key":"1441_CR54","doi-asserted-by":"publisher","unstructured":"Dubey A, Kumar M, Tufail A, Dwivedi VD (2025a) Exploring FDA-approved antiviral drugs for human metapneumovirus treatment: integrative computational insights. bioRxiv. https:\/\/doi.org\/10.1101\/2025.01.13.632889","DOI":"10.1101\/2025.01.13.632889"},{"key":"1441_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025b.102885","volume":"18","author":"A Dubey","year":"2025","unstructured":"Dubey A, Kumar M, Tufail A, Dwivedi VD, Ragusa A (2025bb) Unlocking antiviral potentials of traditional plants: a multi-method computational study against human metapneumovirus (HMPV). J Infect Public Health 18:102885. https:\/\/doi.org\/10.1016\/j.jiph.2025b.102885","journal-title":"J Infect Public Health"},{"key":"1441_CR56","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1099\/jgv.0.000796","volume":"98","author":"J Dubois","year":"2017","unstructured":"Dubois J et al (2017) Mutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia. J Gen Virol 98:1174\u20131180. https:\/\/doi.org\/10.1099\/jgv.0.000796","journal-title":"J Gen Virol"},{"key":"1441_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040164","author":"J Dubois","year":"2019","unstructured":"Dubois J et al (2019) Strain-dependent impact of G and SH deletions provide new insights for live-attenuated HMPV vaccine development. Vaccines. https:\/\/doi.org\/10.3390\/vaccines7040164","journal-title":"Vaccines"},{"key":"1441_CR58","doi-asserted-by":"crossref","unstructured":"Dudley C, Magdaleno R, Harding C, Sharma A, Martin E, Eisenberg M (2025) Mantis: a simulation-grounded foundation model for disease forecasting. ArXiv Preprint arXiv:2508.12260","DOI":"10.1073\/pnas.2602542123"},{"key":"1441_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1023\/a:1010467106305","volume":"20","author":"RE Dutch","year":"2000","unstructured":"Dutch RE, Jardetzky TS, Lamb RA (2000) Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Rep 20:597\u2013612. https:\/\/doi.org\/10.1023\/a:1010467106305","journal-title":"Biosci Rep"},{"key":"1441_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11339-x","volume":"25","author":"M Ehsasatvatan","year":"2025","unstructured":"Ehsasatvatan M, Kohnehrouz BB, Salavatizadeh M (2025a) Immunoinformatic design of chimeric multiepitope vaccine for the prevention of human metapneumovirus (hMPV). BMC Infect Dis 25:964. https:\/\/doi.org\/10.1186\/s12879-025-11339-x","journal-title":"BMC Infect Dis"},{"key":"1441_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11339-x","volume":"25","author":"M Ehsasatvatan","year":"2025","unstructured":"Ehsasatvatan M, Kohnehrouz BB, Salavatizadeh M (2025b) Immunoinformatic design of chimeric multiepitope vaccine for the prevention of human metapneumovirus (hMPV). BMC Infect Dis 25:964. https:\/\/doi.org\/10.1186\/s12879-025-11339-x","journal-title":"BMC Infect Dis"},{"key":"1441_CR62","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1172\/jci62860","volume":"122","author":"JJ Erickson","year":"2012","unstructured":"Erickson JJ et al (2012) Viral acute lower respiratory infections impair CD8\u2009+\u2009T cells through PD-1. J Clin Invest 122:2967\u20132982. https:\/\/doi.org\/10.1172\/jci62860","journal-title":"J Clin Invest"},{"key":"1441_CR63","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.4049\/jimmunol.1302208","volume":"193","author":"JJ Erickson","year":"2014","unstructured":"Erickson JJ, Rogers MC, Hastings AK, Tollefson SJ, Williams JV (2014) Programmed death-1 impairs secondary effector lung CD8\u207a T cells during respiratory virus reinfection. J Immunol 193:5108\u20135117. https:\/\/doi.org\/10.4049\/jimmunol.1302208","journal-title":"J Immunol"},{"key":"1441_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4049\/jimmunol.1502115","volume":"197","author":"JJ Erickson","year":"2016","unstructured":"Erickson JJ, Rogers MC, Tollefson SJ, Boyd KL, Williams JV (2016) Multiple inhibitory pathways contribute to lung CD8\u2009+\u2009T cell impairment and protect against immunopathology during acute viral respiratory infection. J Immunol 197:233\u2013243. https:\/\/doi.org\/10.4049\/jimmunol.1502115","journal-title":"J Immunol"},{"key":"1441_CR65","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.vaccine.2009.11.063","volume":"28","author":"AR Falsey","year":"2010","unstructured":"Falsey AR, Hennessey PA, Formica MA, Criddle MM, Biear JM, Walsh EE (2010) Humoral immunity to human metapneumovirus infection in adults. Vaccine 28:1477\u20131480. https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.063","journal-title":"Vaccine"},{"key":"1441_CR255","doi-asserted-by":"crossref","unstructured":"Faryal B, Ul Abideen Z, Irfan M, Ahmed H, Jalilov F, Abduraximova L, Ashraf GA (2026) Targeted protein degradation in Cancer: PROTACs, new targets, and clinical mechanisms. Biomolecules 16:325","DOI":"10.3390\/biom16020325"},{"key":"1441_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102516","author":"H Fausther-Bovendo","year":"2022","unstructured":"Fausther-Bovendo H et al (2022) A candidate therapeutic monoclonal antibody inhibits both HRSV and HMPV replication in mice. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10102516","journal-title":"Biomedicines"},{"key":"1441_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02327-9","volume":"21","author":"Y Feng","year":"2024","unstructured":"Feng Y, He T, Zhang B, Yuan H, Zhou Y (2024a) Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review. Virol J 21:59. https:\/\/doi.org\/10.1186\/s12985-024-02327-9","journal-title":"Virol J"},{"key":"1441_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02327-9","volume":"21","author":"Y Feng","year":"2024","unstructured":"Feng Y, He T, Zhang B, Yuan H, Zhou Y (2024b) Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review. Virol J 21:59. https:\/\/doi.org\/10.1186\/s12985-024-02327-9","journal-title":"Virol J"},{"key":"1441_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.102135","volume":"43","author":"F Firuzpour","year":"2025","unstructured":"Firuzpour F, Barancheshmeh M, Ziarani FF, Karami L, Aram C (2025) The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation. Biochem Biophys Rep 43:102135. https:\/\/doi.org\/10.1016\/j.bbrep.2025.102135","journal-title":"Biochem Biophys Rep"},{"key":"1441_CR70","first-page":"572","volume":"104","author":"T Francis","year":"1960","unstructured":"Francis T (1960) On the doctrine of original antigenic sin. Proceedings of the American Philosophical Society 104:572\u2013578","journal-title":"Proceedings of the American Philosophical Society"},{"key":"1441_CR71","doi-asserted-by":"publisher","first-page":"e0124082","DOI":"10.1371\/journal.pone.0124082","volume":"10","author":"GA Funchal","year":"2015","unstructured":"Funchal GA et al (2015) Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils. PLoS ONE 10:e0124082. https:\/\/doi.org\/10.1371\/journal.pone.0124082","journal-title":"PLoS ONE"},{"key":"1441_CR72","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/v13030519","volume":"13","author":"NMS G\u00e1lvez","year":"2021","unstructured":"G\u00e1lvez NMS et al (2021a) Host components that modulate the disease caused by hMPV. Viruses 13:519","journal-title":"Viruses"},{"key":"1441_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/v13030519","author":"NMS G\u00e1lvez","year":"2021","unstructured":"G\u00e1lvez NMS et al (2021b) Host components that modulate the disease caused by hMPV. Viruses. https:\/\/doi.org\/10.3390\/v13030519","journal-title":"Viruses"},{"key":"1441_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173504","volume":"12","author":"ML Garc\u00eda-Garc\u00eda","year":"2017","unstructured":"Garc\u00eda-Garc\u00eda ML et al (2017) Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005\u20132014 prospective study. PLoS One 12:e0173504. https:\/\/doi.org\/10.1371\/journal.pone.0173504","journal-title":"PLoS One"},{"key":"1441_CR75","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1099\/0022-1317-83-4-753","volume":"83","author":"R Ghildyal","year":"2002","unstructured":"Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J (2002) Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol 83:753\u2013757","journal-title":"J Gen Virol"},{"key":"1441_CR76","doi-asserted-by":"publisher","unstructured":"Gilman MS et al (2016) Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Sci Immunol 1. https:\/\/doi.org\/10.1126\/sciimmunol.aaj1879","DOI":"10.1126\/sciimmunol.aaj1879"},{"key":"1441_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2025a.105758","volume":"131","author":"S Gnanasekaran","year":"2025","unstructured":"Gnanasekaran S, Bashar MA, Rajan AK, Prabhat P (2025aa) Emerging threat of human metapneumovirus (HMPV) and strategies for its containment and control. Infect Genet Evol 131:105758. https:\/\/doi.org\/10.1016\/j.meegid.2025a.105758","journal-title":"Infect Genet Evol"},{"key":"1441_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2025b.105758","volume":"131","author":"S Gnanasekaran","year":"2025","unstructured":"Gnanasekaran S, Bashar MDA, Rajan AK, Prabhat P (2025bb) Emerging threat of human metapneumovirus (HMPV) and strategies for its containment and control. Infect Genet Evol 131:105758. https:\/\/doi.org\/10.1016\/j.meegid.2025b.105758","journal-title":"Infect Genet Evol"},{"key":"1441_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45480-z","volume":"15","author":"KJ Gonzalez","year":"2024","unstructured":"Gonzalez KJ et al (2024) A general computational design strategy for stabilizing viral class I fusion proteins. Nat Commun 15:1335. https:\/\/doi.org\/10.1038\/s41467-024-45480-z","journal-title":"Nat Commun"},{"key":"1441_CR80","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2018.01.005","volume":"48","author":"E Goodwin","year":"2018","unstructured":"Goodwin E et al (2018) Infants infected with respiratory syncytial virus generate potent neutralizing antibodies that lack somatic hypermutation. Immunity 48:339-349.e335. https:\/\/doi.org\/10.1016\/j.immuni.2018.01.005","journal-title":"Immunity"},{"key":"1441_CR81","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4049\/jimmunol.0902750","volume":"184","author":"N Goutagny","year":"2010","unstructured":"Goutagny N et al (2010) Cell Type-Specific recognition of human metapneumoviruses (HMPVs) by retinoic Acid-Inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J Immunol 184:1168\u20131179. https:\/\/doi.org\/10.4049\/jimmunol.0902750","journal-title":"J Immunol"},{"key":"1441_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102399","volume":"6","author":"C Guo","year":"2025","unstructured":"Guo C et al (2025) In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence. Cell Rep Med 6:102399. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102399","journal-title":"Cell Rep Med"},{"key":"1441_CR83","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/irv.13034","volume":"16","author":"K Hacker","year":"2022","unstructured":"Hacker K et al (2022) Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua. Influenza Other Respir Viruses 16:1112\u20131121. https:\/\/doi.org\/10.1111\/irv.13034","journal-title":"Influenza Other Respir Viruses"},{"key":"1441_CR84","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1128\/aac.50.2.774-777.2006","volume":"50","author":"M-\u00c8 Hamelin","year":"2006","unstructured":"Hamelin M-\u00c8, Prince GA, Boivin G (2006) Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother 50:774\u2013777. https:\/\/doi.org\/10.1128\/aac.50.2.774-777.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"1441_CR85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2010.07.001","volume":"88","author":"ME Hamelin","year":"2010","unstructured":"Hamelin ME et al (2010) Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antivir Res 88:31\u201337. https:\/\/doi.org\/10.1016\/j.antiviral.2010.07.001","journal-title":"Antivir Res"},{"key":"1441_CR86","doi-asserted-by":"publisher","first-page":"10730","DOI":"10.1128\/jvi.75.22.10730-10737.2001","volume":"75","author":"LM Haynes","year":"2001","unstructured":"Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA (2001) Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75:10730\u201310737. https:\/\/doi.org\/10.1128\/jvi.75.22.10730-10737.2001","journal-title":"J Virol"},{"key":"1441_CR87","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2927","author":"AK Haynes","year":"2016","unstructured":"Haynes AK, Fowlkes AL, Schneider E, Mutuc JD, Armstrong GL, Gerber SI (2016) Human metapneumovirus circulation in the United States, 2008 to 2014. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2015-2927","journal-title":"Pediatrics"},{"key":"1441_CR88","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526\u20131529. https:\/\/doi.org\/10.1126\/science.1093620","journal-title":"Science"},{"key":"1441_CR89","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1086\/526536","volume":"197","author":"KA Herd","year":"2008","unstructured":"Herd KA, Nissen MD, Hopkins PM, Sloots TP, Tindle RW (2008) Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. J Infect Dis 197:584\u2013592. https:\/\/doi.org\/10.1086\/526536","journal-title":"J Infect Dis"},{"key":"1441_CR90","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1099\/vir.0.015396-0","volume":"91","author":"KA Herd","year":"2010","unstructured":"Herd KA, Nelson M, Mahalingam S, Tindle RW (2010) Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus. J Gen Virol 91:1302\u20131310. https:\/\/doi.org\/10.1099\/vir.0.015396-0","journal-title":"J Gen Virol"},{"key":"1441_CR91","doi-asserted-by":"publisher","first-page":"8264","DOI":"10.1128\/jvi.78.15.8264-8270.2004","volume":"78","author":"S Herfst","year":"2004","unstructured":"Herfst S et al (2004) Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. J Virol 78:8264\u20138270. https:\/\/doi.org\/10.1128\/jvi.78.15.8264-8270.2004","journal-title":"J Virol"},{"key":"1441_CR92","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1099\/vir.0.2008\/002022-0","volume":"89","author":"S Herfst","year":"2008","unstructured":"Herfst S et al (2008a) Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters. J Gen Virol 89:1553\u20131562. https:\/\/doi.org\/10.1099\/vir.0.2008\/002022-0","journal-title":"J Gen Virol"},{"key":"1441_CR93","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1128\/jvi.00472-08","volume":"82","author":"S Herfst","year":"2008","unstructured":"Herfst S et al (2008) Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J Virol 82:8891\u20138895. https:\/\/doi.org\/10.1128\/jvi.00472-08","journal-title":"J Virol"},{"key":"1441_CR94","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1016\/j.vaccine.2008.05.052","volume":"26","author":"S Herfst","year":"2008","unstructured":"Herfst S et al (2008c) Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Vaccine 26:4224\u20134230. https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.052","journal-title":"Vaccine"},{"key":"1441_CR95","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cll.2009.10.002","volume":"30","author":"CR Hermos","year":"2010","unstructured":"Hermos CR, Vargas SO, McAdam AJ (2010) Human metapneumovirus. Clin Lab Med 30:131\u2013148. https:\/\/doi.org\/10.1016\/j.cll.2009.10.002","journal-title":"Clin Lab Med"},{"key":"1441_CR96","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1128\/jvi.12.6.1457-1465.1973","volume":"12","author":"M Homma","year":"1973","unstructured":"Homma M, Ouchi M (1973) Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol 12:1457\u20131465. https:\/\/doi.org\/10.1128\/jvi.12.6.1457-1465.1973","journal-title":"J Virol"},{"key":"1441_CR97","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","volume":"13","author":"CL Hsieh","year":"2022","unstructured":"Hsieh CL et al (2022) Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins. Nat Commun 13:1299. https:\/\/doi.org\/10.1038\/s41467-022-28931-3","journal-title":"Nat Commun"},{"key":"1441_CR98","doi-asserted-by":"publisher","first-page":"e0059321","DOI":"10.1128\/jvi.00593-21","volume":"95","author":"J Huang","year":"2021","unstructured":"Huang J et al (2021) Structure, Immunogenicity, and Conformation-Dependent receptor binding of the postfusion human metapneumovirus F protein. J Virol 95:e0059321. https:\/\/doi.org\/10.1128\/jvi.00593-21","journal-title":"J Virol"},{"key":"1441_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.941865","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Miller RJ, Mousa JJ (2022) A pan-pneumovirus vaccine based on immunodominant epitopes of the fusion protein. Front Immunol 13:941865. https:\/\/doi.org\/10.3389\/fimmu.2022.941865","journal-title":"Front Immunol"},{"key":"1441_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020196","author":"I Isakova-Sivak","year":"2020","unstructured":"Isakova-Sivak I et al (2020) Recombinant live attenuated influenza vaccine viruses carrying conserved T-cell epitopes of human adenoviruses induce functional cytotoxic T-cell responses and protect mice against both infections. Vaccines. https:\/\/doi.org\/10.3390\/vaccines8020196","journal-title":"Vaccines"},{"key":"1441_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-29906-2","volume":"16","author":"MA Izhari","year":"2025","unstructured":"Izhari MA et al (2025) Rational design and in silico characterization of a multiepitope mRNA vaccine candidate against human metapneumovirus (hMPV) using reverse vaccinology and immunoinformatics approaches. Sci Rep 16:540. https:\/\/doi.org\/10.1038\/s41598-025-29906-2","journal-title":"Sci Rep"},{"key":"1441_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/v14040677","author":"ST Jesse","year":"2022","unstructured":"Jesse ST, Ludlow M, Osterhaus A (2022) Zoonotic origins of human metapneumovirus: a journey from birds to humans. Viruses. https:\/\/doi.org\/10.3390\/v14040677","journal-title":"Viruses"},{"key":"1441_CR103","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2217076","volume":"19","author":"Y Jia","year":"2023","unstructured":"Jia Y, Fu B, Dong L, Zhao M (2023) Sweet syndrome induced by SARS-CoV-2 vaccines: a systematic review of patient-report studies. Hum Vaccin Immunother 19:2217076. https:\/\/doi.org\/10.1080\/21645515.2023.2217076","journal-title":"Hum Vaccin Immunother"},{"key":"1441_CR104","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15585\/mmwr.mm7411a1","volume":"74","author":"NB Jobe","year":"2025","unstructured":"Jobe NB, Rose E, Winn AK, Goldstein L, Schneider ZD, Silk BJ (2025) Human metapneumovirus seasonality and co-circulation with respiratory syncytial virus - United States, 2014\u20132024. MMWR Morb Mortal Wkly Rep 74:182\u2013187. https:\/\/doi.org\/10.15585\/mmwr.mm7411a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1441_CR105","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1469-0691.2010.03191.x","volume":"16","author":"P Jokela","year":"2010","unstructured":"Jokela P, Piiparinen H, Luiro K, Lappalainen M (2010) Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay. Clin Microbiol Infect 16:1568\u20131573. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03191.x","journal-title":"Clin Microbiol Infect"},{"key":"1441_CR106","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ni0602-499","volume":"3","author":"M Jurk","year":"2002","unstructured":"Jurk M et al (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3:499. https:\/\/doi.org\/10.1038\/ni0602-499","journal-title":"Nat Immunol"},{"key":"1441_CR107","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/cmr.00014-06","volume":"19","author":"JS Kahn","year":"2006","unstructured":"Kahn JS (2006) Epidemiology of human metapneumovirus. Clin Microbiol Rev 19:546\u2013557. https:\/\/doi.org\/10.1128\/cmr.00014-06","journal-title":"Clin Microbiol Rev"},{"key":"1441_CR108","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/jvi.65.3.1057-1065.1991","volume":"65","author":"PE Kaptur","year":"1991","unstructured":"Kaptur PE, Rhodes RB, Lyles DS (1991) Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids. J Virol 65:1057\u20131065","journal-title":"J Virol"},{"key":"1441_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2025.1645467","author":"J Kaur","year":"2025","unstructured":"Kaur J, Butt ZA (2025) AI-driven epidemic intelligence: the future of outbreak detection and response. Front Artif Intell. https:\/\/doi.org\/10.3389\/frai.2025.1645467","journal-title":"Front Artif Intell"},{"key":"1441_CR110","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","volume":"13","author":"T Kawai","year":"2006","unstructured":"Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13:816\u2013825. https:\/\/doi.org\/10.1038\/sj.cdd.4401850","journal-title":"Cell Death Differ"},{"key":"1441_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","volume":"18","author":"SC Kim","year":"2022","unstructured":"Kim SC et al (2022) Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Mol Cell Toxicol 18:1\u20138. https:\/\/doi.org\/10.1007\/s13273-021-00171-4","journal-title":"Mol Cell Toxicol"},{"key":"1441_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050523","author":"M Kishko","year":"2025","unstructured":"Kishko M et al (2025) A computationally designed prefusion stabilized human metapneumovirus fusion protein vaccine antigen elicited a potent neutralization response. Vaccines. https:\/\/doi.org\/10.3390\/vaccines13050523","journal-title":"Vaccines"},{"key":"1441_CR113","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1097\/MPH.0b013e3182915d2d","volume":"35","author":"L Kitanovski","year":"2013","unstructured":"Kitanovski L et al (2013a) Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG. J Pediatr Hematol Oncol 35:e311\u2013e313. https:\/\/doi.org\/10.1097\/MPH.0b013e3182915d2d","journal-title":"J Pediatr Hematol Oncol"},{"key":"1441_CR114","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1097\/MPH.0b013e3182915d2d","volume":"35","author":"L Kitanovski","year":"2013","unstructured":"Kitanovski L et al (2013b) Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG. J Pediatr Hematol Oncol 35:e311-313. https:\/\/doi.org\/10.1097\/MPH.0b013e3182915d2d","journal-title":"J Pediatr Hematol Oncol"},{"key":"1441_CR115","doi-asserted-by":"publisher","first-page":"8560","DOI":"10.1128\/jvi.00699-08","volume":"82","author":"D Kolli","year":"2008","unstructured":"Kolli D et al (2008) T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol 82:8560\u20138569. https:\/\/doi.org\/10.1128\/jvi.00699-08","journal-title":"J Virol"},{"key":"1441_CR116","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.3390\/v4123551","volume":"4","author":"D Kolli","year":"2012","unstructured":"Kolli D, Bao X, Casola A (2012) Human metapneumovirus antagonism of innate immune responses. Viruses 4:3551\u20133571. https:\/\/doi.org\/10.3390\/v4123551","journal-title":"Viruses"},{"key":"1441_CR117","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2019.05.001","volume":"168","author":"T Kotomina","year":"2019","unstructured":"Kotomina T et al (2019) Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. Antiviral Res 168:9\u201317. https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.001","journal-title":"Antiviral Res"},{"key":"1441_CR118","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","volume":"190","author":"Y Kou","year":"2017","unstructured":"Kou Y et al (2017) Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis. Immunol Lett 190:51\u201357. https:\/\/doi.org\/10.1016\/j.imlet.2017.07.007","journal-title":"Immunol Lett"},{"key":"1441_CR119","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-024-08564-w","volume":"638","author":"MUG Kraemer","year":"2025","unstructured":"Kraemer MUG et al (2025) Artificial intelligence for modelling infectious disease epidemics. Nature 638:623\u2013635. https:\/\/doi.org\/10.1038\/s41586-024-08564-w","journal-title":"Nature"},{"key":"1441_CR120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4049\/jimmunol.180.1.309","volume":"180","author":"S Kreiter","year":"2008","unstructured":"Kreiter S et al (2008) Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J Immunol 180:309\u2013318. https:\/\/doi.org\/10.4049\/jimmunol.180.1.309","journal-title":"J Immunol"},{"key":"1441_CR121","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2004.06.007","volume":"21","author":"A Krug","year":"2004","unstructured":"Krug A et al (2004a) TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107\u2013119. https:\/\/doi.org\/10.1016\/j.immuni.2004.06.007","journal-title":"Immunity"},{"key":"1441_CR122","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2003-08-2674","volume":"103","author":"A Krug","year":"2004","unstructured":"Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M (2004b) Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103:1433\u20131437. https:\/\/doi.org\/10.1182\/blood-2003-08-2674","journal-title":"Blood"},{"key":"1441_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025a.104364","volume":"30","author":"N Kr\u00fcger","year":"2025","unstructured":"Kr\u00fcger N, Laufer SA, Pillaiyar T (2025aa) An overview of progress in human metapneumovirus (hMPV) research: structure, function, and therapeutic opportunities. Drug Discov Today 30:104364. https:\/\/doi.org\/10.1016\/j.drudis.2025a.104364","journal-title":"Drug Discov Today"},{"key":"1441_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025b.104364","volume":"30","author":"N Kr\u00fcger","year":"2025","unstructured":"Kr\u00fcger N, Laufer SA, Pillaiyar T (2025bb) An overview of progress in human metapneumovirus (hMPV) research: structure, function, and therapeutic opportunities. Drug Discov Today 30:104364. https:\/\/doi.org\/10.1016\/j.drudis.2025b.104364","journal-title":"Drug Discov Today"},{"key":"1441_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2024.100679","volume":"6","author":"D Kulkarni","year":"2025","unstructured":"Kulkarni D et al (2025a) The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis. Lancet Healthy Longev 6:100679. https:\/\/doi.org\/10.1016\/j.lanhl.2024.100679","journal-title":"Lancet Healthy Longev"},{"key":"1441_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2024.100679","volume":"6","author":"D Kulkarni","year":"2025","unstructured":"Kulkarni D et al (2025b) The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis. Lancet Healthy Longev 6:100679. https:\/\/doi.org\/10.1016\/j.lanhl.2024.100679","journal-title":"Lancet Healthy Longev"},{"key":"1441_CR127","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s13337-018-0498-5","volume":"29","author":"P Kumar","year":"2018","unstructured":"Kumar P, Srivastava M (2018) Prophylactic and therapeutic approaches for human metapneumovirus. Virusdisease 29:434\u2013444. https:\/\/doi.org\/10.1007\/s13337-018-0498-5","journal-title":"Virusdisease"},{"key":"1441_CR128","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/80833","volume":"1","author":"EA Kurt-Jones","year":"2000","unstructured":"Kurt-Jones EA et al (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398\u2013401. https:\/\/doi.org\/10.1038\/80833","journal-title":"Nat Immunol"},{"key":"1441_CR129","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1016\/j.vaccine.2019.09.041","volume":"37","author":"YM Kwon","year":"2019","unstructured":"Kwon YM et al (2019) Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles. Vaccine 37:6656\u20136664. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.041","journal-title":"Vaccine"},{"key":"1441_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1993.1561","volume":"197","author":"RA Lamb","year":"1993","unstructured":"Lamb RA (1993) Paramyxovirus fusion: a hypothesis for changes. Virology 197:1\u201311. https:\/\/doi.org\/10.1006\/viro.1993.1561","journal-title":"Virology"},{"key":"1441_CR131","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.sbi.2007.08.016","volume":"17","author":"RA Lamb","year":"2007","unstructured":"Lamb RA, Jardetzky TS (2007) Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol 17:427\u2013436. https:\/\/doi.org\/10.1016\/j.sbi.2007.08.016","journal-title":"Curr Opin Struct Biol"},{"key":"1441_CR132","doi-asserted-by":"publisher","first-page":"198.192","DOI":"10.4049\/jimmunol.202.Supp.198.2","volume":"202","author":"KD Lamens","year":"2019","unstructured":"Lamens KD, Rogers MC, Tometich JT, Hand TW, Williams JV (2019) Uncharted territory: the CD4\u2009+\u2009T cell response to human metapneumovirus. J Immunol 202:198.192-198.192","journal-title":"J Immunol"},{"key":"1441_CR133","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","volume":"32","author":"A Lamichhane","year":"2014","unstructured":"Lamichhane A, Azegamia T, Kiyonoa H (2014) The mucosal immune system for vaccine development. Vaccine 32:6711\u20136723. https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.089","journal-title":"Vaccine"},{"key":"1441_CR134","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1469-0691.2004.00980.x","volume":"10","author":"K Latiff","year":"2004","unstructured":"Latiff K, Meanger J, Mills J, Ghildyal R (2004) Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses. Clin Microbiol Infect 10:945\u2013948","journal-title":"Clin Microbiol Infect"},{"key":"1441_CR135","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.str.2013.10.013","volume":"22","author":"C Leyrat","year":"2014","unstructured":"Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM (2014) Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure 22:136\u2013148. https:\/\/doi.org\/10.1016\/j.str.2013.10.013","journal-title":"Structure"},{"key":"1441_CR136","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000445059","volume":"58","author":"X Li","year":"2015","unstructured":"Li X et al (2015) Design and evaluation of a multi-epitope peptide of human metapneumovirus. Intervirology 58:403\u2013412. https:\/\/doi.org\/10.1159\/000445059","journal-title":"Intervirology"},{"key":"1441_CR137","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1016\/s2214-109x(19)30264-5","volume":"7","author":"Y Li","year":"2019","unstructured":"Li Y et al (2019) Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health 7:e1031\u2013e1045. https:\/\/doi.org\/10.1016\/s2214-109x(19)30264-5","journal-title":"Lancet Glob Health"},{"key":"1441_CR138","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1021\/acsnano.2c01283","volume":"16","author":"M Li","year":"2022","unstructured":"Li M et al (2022) Virus-like particle-templated silica-adjuvanted nanovaccines with enhanced humoral and cellular immunity. ACS Nano 16:10482\u201310495. https:\/\/doi.org\/10.1021\/acsnano.2c01283","journal-title":"ACS Nano"},{"key":"1441_CR139","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1099\/vir.0.2008\/000778-0","volume":"89","author":"S Liao","year":"2008","unstructured":"Liao S et al (2008) Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J Gen Virol 89:1978\u20131986. https:\/\/doi.org\/10.1099\/vir.0.2008\/000778-0","journal-title":"J Gen Virol"},{"key":"1441_CR140","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1128\/cvi.00145-13","volume":"20","author":"P Liu","year":"2013","unstructured":"Liu P, Shu Z, Qin X, Dou Y, Zhao Y, Zhao X (2013) A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB\/c mice. Clin Vaccine Immunol 20:1246\u20131254. https:\/\/doi.org\/10.1128\/cvi.00145-13","journal-title":"Clin Vaccine Immunol"},{"key":"1441_CR141","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1753425908095957","volume":"14","author":"R Lizundia","year":"2008","unstructured":"Lizundia R, Sauter KS, Taylor G, Werling D (2008) Host species-specific usage of the TLR4-LPS receptor complex. Innate Immun 14:223\u2013231. https:\/\/doi.org\/10.1177\/1753425908095957","journal-title":"Innate Immun"},{"key":"1441_CR142","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/cvi.00398-09","volume":"17","author":"J L\u00fcsebrink","year":"2010","unstructured":"L\u00fcsebrink J et al (2010) High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin Vaccine Immunol 17:481\u2013484. https:\/\/doi.org\/10.1128\/cvi.00398-09","journal-title":"Clin Vaccine Immunol"},{"key":"1441_CR143","doi-asserted-by":"publisher","first-page":"2293300","DOI":"10.1080\/21645515.2023.2293300","volume":"19","author":"S Ma","year":"2023","unstructured":"Ma S et al (2023) Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus. Hum Vaccin Immunother 19:2293300. https:\/\/doi.org\/10.1080\/21645515.2023.2293300","journal-title":"Hum Vaccin Immunother"},{"key":"1441_CR144","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","volume":"11","author":"K Maman","year":"2015","unstructured":"Maman K, Z\u00f6llner Y, Greco D, Duru G, Sendyona S, Remy V (2015) The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother 11:2132\u20132141. https:\/\/doi.org\/10.1080\/21645515.2015.1044180","journal-title":"Hum Vaccin Immunother"},{"key":"1441_CR145","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00425-015-2277-5","volume":"242","author":"VA M\u00e1rquez-Escobar","year":"2015","unstructured":"M\u00e1rquez-Escobar VA, Tirado-Mendoza R, Noyola DE, Guti\u00e9rrez-Ortega A, Alpuche-Sol\u00eds \u00c1G (2015) HRA2pl peptide: a fusion inhibitor for human metapneumovirus produced in tobacco plants by transient transformation. Planta 242:69\u201376","journal-title":"Planta"},{"key":"1441_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126210","author":"AG Martinez-Perez","year":"2021","unstructured":"Martinez-Perez AG et al (2021) 4-1BBL as a mediator of cross-talk between innate, adaptive, and regulatory immunity against cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22126210","journal-title":"Int J Mol Sci"},{"key":"1441_CR147","doi-asserted-by":"publisher","first-page":"e1005859","DOI":"10.1371\/journal.ppat.1005859","volume":"12","author":"V M\u00e1s","year":"2016","unstructured":"M\u00e1s V et al (2016) Engineering, structure and immunogenicity of the human metapneumovirus F protein in the postfusion conformation. PLoS Pathog 12:e1005859. https:\/\/doi.org\/10.1371\/journal.ppat.1005859","journal-title":"PLoS Pathog"},{"key":"1441_CR148","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1128\/jvi.02423-06","volume":"81","author":"GA Melendi","year":"2007","unstructured":"Melendi GA et al (2007) Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus. J Virol 81:11461\u201311467. https:\/\/doi.org\/10.1128\/jvi.02423-06","journal-title":"J Virol"},{"key":"1441_CR149","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.20171068","volume":"215","author":"AV Menk","year":"2018","unstructured":"Menk AV et al (2018) 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. J Exp Med 215:1091\u20131100. https:\/\/doi.org\/10.1084\/jem.20171068","journal-title":"J Exp Med"},{"key":"1441_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1125135","volume":"13","author":"UC Meza","year":"2023","unstructured":"Meza UC, Lara NP, G\u00f3mez LC, Rodr\u00edguez MS, Hern\u00e1ndez JRA, Mendoza RT (2023) The HRA2pl fusion peptide exerts in vitro antiviral activity against human respiratory paramyxoviruses and pneumoviruses. Front Cell Infect Microbiol 13:1125135","journal-title":"Front Cell Infect Microbiol"},{"key":"1441_CR151","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78354","volume":"17","author":"B Mishra","year":"2025","unstructured":"Mishra B, Mohapatra D, Tripathy M, Mamidi P, Mohapatra PR (2025) A re-emerging respiratory virus: human metapneumovirus (hMPV). Cureus 17:e78354. https:\/\/doi.org\/10.7759\/cureus.78354","journal-title":"Cureus"},{"key":"1441_CR152","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12985-025-02782-y","volume":"22","author":"K Mohammadi","year":"2025","unstructured":"Mohammadi K et al (2025a) Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses-a comprehensive review. Virol J 22:150. https:\/\/doi.org\/10.1186\/s12985-025-02782-y","journal-title":"Virol J"},{"key":"1441_CR153","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12985-025-02782-y","volume":"22","author":"K Mohammadi","year":"2025","unstructured":"Mohammadi K et al (2025b) Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses\u2014a comprehensive review. Virol J 22:150. https:\/\/doi.org\/10.1186\/s12985-025-02782-y","journal-title":"Virol J"},{"key":"1441_CR154","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","volume":"31","author":"DM Morens","year":"2023","unstructured":"Morens DM, Taubenberger JK, Fauci AS (2023) Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe 31:146\u2013157. https:\/\/doi.org\/10.1016\/j.chom.2022.11.016","journal-title":"Cell Host Microbe"},{"key":"1441_CR155","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1128\/jvi.00671-08","volume":"83","author":"MR Murawski","year":"2009","unstructured":"Murawski MR et al (2009) Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 83:1492\u20131500. https:\/\/doi.org\/10.1128\/jvi.00671-08","journal-title":"J Virol"},{"key":"1441_CR156","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1080\/23744235.2016.1204661","volume":"48","author":"F Niggli","year":"2016","unstructured":"Niggli F, Huber LC, Benden C, Schuurmans MM (2016) Human metapneumovirus in lung transplant recipients: characteristics and outcomes. Infect Dis (Lond) 48:852\u2013856","journal-title":"Infect Dis (Lond)"},{"key":"1441_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288271","volume":"18","author":"A Oey","year":"2023","unstructured":"Oey A et al (2023) Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: safety, efficacy, and pharmacokinetic results. PLoS One 18:e0288271. https:\/\/doi.org\/10.1371\/journal.pone.0288271","journal-title":"PLoS One"},{"key":"1441_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00899-9","volume":"9","author":"D Ogonczyk-Makowska","year":"2024","unstructured":"Ogonczyk-Makowska D et al (2024) Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice. NPJ Vaccines 9:111. https:\/\/doi.org\/10.1038\/s41541-024-00899-9","journal-title":"NPJ Vaccines"},{"key":"1441_CR159","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/jmv.21920","volume":"82","author":"M Okamoto","year":"2010","unstructured":"Okamoto M et al (2010) Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults. J Med Virol 82:2092\u20132096. https:\/\/doi.org\/10.1002\/jmv.21920","journal-title":"J Med Virol"},{"key":"1441_CR160","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jmv.21436","volume":"81","author":"DB Oliveira","year":"2009","unstructured":"Oliveira DB et al (2009) Epidemiology and genetic variability of human metapneumovirus during a 4-year-long study in Southeastern Brazil. J Med Virol 81:915\u2013921. https:\/\/doi.org\/10.1002\/jmv.21436","journal-title":"J Med Virol"},{"key":"1441_CR161","doi-asserted-by":"publisher","first-page":"175","DOI":"10.15252\/emmm.201708078","volume":"10","author":"E Olmedillas","year":"2018","unstructured":"Olmedillas E et al (2018) Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses. EMBO Mol Med 10:175\u2013187. https:\/\/doi.org\/10.15252\/emmm.201708078","journal-title":"EMBO Mol Med"},{"key":"1441_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0094-0","volume":"4","author":"MT Orr","year":"2019","unstructured":"Orr MT et al (2019) Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology. NPJ Vaccines 4:1. https:\/\/doi.org\/10.1038\/s41541-018-0094-0","journal-title":"NPJ Vaccines"},{"key":"1441_CR163","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1128\/jvi.68.4.2772-2776.1994","volume":"68","author":"D Ortmann","year":"1994","unstructured":"Ortmann D, Ohuchi M, Angliker H, Shaw E, Garten W, Klenk HD (1994) Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, Furin and Kex2. J Virol 68:2772\u20132776. https:\/\/doi.org\/10.1128\/jvi.68.4.2772-2776.1994","journal-title":"J Virol"},{"key":"1441_CR164","doi-asserted-by":"publisher","first-page":"e1011584","DOI":"10.1371\/journal.ppat.1011584","volume":"19","author":"L Ou","year":"2023","unstructured":"Ou L et al (2023) Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus. PLoS Pathog 19:e1011584. https:\/\/doi.org\/10.1371\/journal.ppat.1011584","journal-title":"PLoS Pathog"},{"key":"1441_CR165","doi-asserted-by":"publisher","first-page":"12714","DOI":"10.1128\/jvi.79.20.12714-12720.2005","volume":"79","author":"CT Pager","year":"2005","unstructured":"Pager CT, Dutch RE (2005) Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol 79:12714\u201312720. https:\/\/doi.org\/10.1128\/jvi.79.20.12714-12720.2005","journal-title":"J Virol"},{"key":"1441_CR166","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-019-1759-1","volume":"577","author":"J Pan","year":"2020","unstructured":"Pan J et al (2020) Structure of the human metapneumovirus polymerase phosphoprotein complex. Nature 577:275\u2013279. https:\/\/doi.org\/10.1038\/s41586-019-1759-1","journal-title":"Nature"},{"key":"1441_CR167","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2014.03.1394","volume":"25","author":"S Panda","year":"2014","unstructured":"Panda S, Mohakud NK, Pena L, Kumar S (2014) Human metapneumovirus: review of an important respiratory pathogen. Int J Infect Dis 25:45\u201352. https:\/\/doi.org\/10.1016\/j.ijid.2014.03.1394","journal-title":"Int J Infect Dis"},{"key":"1441_CR168","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4049\/immunohorizons.2300026","volume":"7","author":"OB Parks","year":"2023","unstructured":"Parks OB, Eddens T, Zhang Y, Oury TD, McElroy A, Williams JV (2023) Human metapneumovirus reinfection in aged mice recapitulates increased disease severity in elderly humans infected with human metapneumovirus. Immunohorizons 7:398\u2013411. https:\/\/doi.org\/10.4049\/immunohorizons.2300026","journal-title":"Immunohorizons"},{"key":"1441_CR169","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3201\/eid0809.020238","volume":"8","author":"G Pelletier","year":"2002","unstructured":"Pelletier G, D\u00e9ry P, Abed Y, Boivin G (2002) Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. Emerg Infect Dis 8:976\u2013978. https:\/\/doi.org\/10.3201\/eid0809.020238","journal-title":"Emerg Infect Dis"},{"key":"1441_CR170","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1086\/340518","volume":"185","author":"TC Peret","year":"2002","unstructured":"Peret TC et al (2002) Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis 185:1660\u20131663. https:\/\/doi.org\/10.1086\/340518","journal-title":"J Infect Dis"},{"key":"1441_CR171","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.vaccine.2020.01.047","volume":"38","author":"M Pilaev","year":"2020","unstructured":"Pilaev M et al (2020) Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice. Vaccine 38:2122\u20132127. https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.047","journal-title":"Vaccine"},{"key":"1441_CR172","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/s0074-02762011000100009","volume":"106","author":"DA Pilger","year":"2011","unstructured":"Pilger DA, Cantarelli VV, Amantea SL, Leistner-Segal S (2011) Detection of human bocavirus and human metapneumovirus by real-time PCR from patients with respiratory symptoms in southern Brazil. Mem Inst Oswaldo Cruz 106:56\u201360. https:\/\/doi.org\/10.1590\/s0074-02762011000100009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1441_CR173","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/infdis\/jiad268","volume":"229","author":"JL Pi\u00f1ana","year":"2024","unstructured":"Pi\u00f1ana JL et al (2024) Upper and\/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation. J Infect Dis 229:83\u201394. https:\/\/doi.org\/10.1093\/infdis\/jiad268","journal-title":"J Infect Dis"},{"key":"1441_CR174","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/v17081140","volume":"17","author":"N Principi","year":"2025","unstructured":"Principi N, Fainardi V, Esposito S (2025) Human metapneumovirus: a narrative review on emerging strategies for prevention and treatment. Viruses 17:1140","journal-title":"Viruses"},{"key":"1441_CR175","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/ijp.ijp_559_25","volume":"57","author":"H Rajput","year":"2025","unstructured":"Rajput H et al (2025) In Silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparedness. Indian J Pharmacol 57:308\u2013321. https:\/\/doi.org\/10.4103\/ijp.ijp_559_25","journal-title":"Indian J Pharmacol"},{"key":"1441_CR176","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1073\/pnas.042355399","volume":"99","author":"JC Rassa","year":"2002","unstructured":"Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR (2002) Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A 99:2281\u20132286. https:\/\/doi.org\/10.1073\/pnas.042355399","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1441_CR177","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ijbiomac.2022.12.066","volume":"226","author":"N Rcheulishvili","year":"2023","unstructured":"Rcheulishvili N et al (2023) Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic\/pandemic preparedness. Int J Biol Macromol 226:885\u2013899. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.12.066","journal-title":"Int J Biol Macromol"},{"key":"1441_CR178","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.medcle.2016.11.021","volume":"147","author":"J Reina","year":"2016","unstructured":"Reina J, Murillas J, Taboada C (2016) Acute respiratory infection caused by the human metapneumovirus: analysis of 39 cases. Med Clin (Engl Ed) 147:418\u2013419. https:\/\/doi.org\/10.1016\/j.medcle.2016.11.021","journal-title":"Med Clin (Engl Ed)"},{"key":"1441_CR179","doi-asserted-by":"publisher","first-page":"13049","DOI":"10.1128\/jvi.01248-12","volume":"86","author":"J Ren","year":"2012","unstructured":"Ren J et al (2012) Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS. J Virol 86:13049\u201313061. https:\/\/doi.org\/10.1128\/jvi.01248-12","journal-title":"J Virol"},{"key":"1441_CR180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091865","volume":"9","author":"J Ren","year":"2014","unstructured":"Ren J, Liu G, Go J, Kolli D, Zhang G, Bao X (2014) Human metapneumovirus M2-2 protein inhibits innate immune response in monocyte-derived dendritic cells. PLoS One 9:e91865. https:\/\/doi.org\/10.1371\/journal.pone.0091865","journal-title":"PLoS One"},{"key":"1441_CR181","doi-asserted-by":"publisher","first-page":"e12627","DOI":"10.7554\/eLife.12627","volume":"5","author":"M Renner","year":"2016","unstructured":"Renner M et al (2016) Nucleocapsid assembly in pneumoviruses is regulated by conformational switching of the N protein. Elife 5:e12627","journal-title":"Elife"},{"key":"1441_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14448-z","volume":"7","author":"M Renner","year":"2017","unstructured":"Renner M, Paesen GC, Grison CM, Granier S, Grimes JM, Leyrat C (2017) Structural dissection of human metapneumovirus phosphoprotein using small angle x-ray scattering. Sci Rep 7:14865","journal-title":"Sci Rep"},{"key":"1441_CR183","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1099\/jgv.0.000959","volume":"98","author":"B Rima","year":"2017","unstructured":"Rima B et al (2017) ICTV virus taxonomy profile: pneumoviridae. J Gen Virol 98:2912\u20132913. https:\/\/doi.org\/10.1099\/jgv.0.000959","journal-title":"J Gen Virol"},{"key":"1441_CR184","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.4049\/jimmunol.1800096","volume":"201","author":"MC Rogers","year":"2018","unstructured":"Rogers MC et al (2018) CD4(+) regulatory T cells exert differential functions during early and late stages of the immune response to respiratory viruses. J Immunol 201:1253\u20131266. https:\/\/doi.org\/10.4049\/jimmunol.1800096","journal-title":"J Immunol"},{"key":"1441_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111399","volume":"40","author":"SA Rush","year":"2022","unstructured":"Rush SA et al (2022) Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus. Cell Rep 40:111399. https:\/\/doi.org\/10.1016\/j.celrep.2022.111399","journal-title":"Cell Rep"},{"key":"1441_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020109","author":"CJ Russell","year":"2020","unstructured":"Russell CJ, Penkert RR, Kim S, Hurwitz JL (2020) Human metapneumovirus: a largely unrecognized threat to human health. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9020109","journal-title":"Pathogens"},{"key":"1441_CR187","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ymthe.2019.05.012","volume":"27","author":"Y Rybakova","year":"2019","unstructured":"Rybakova Y et al (2019) mRNA delivery for therapeutic anti-HER2 antibody expression in vivo. Mol Ther 27:1415\u20131423. https:\/\/doi.org\/10.1016\/j.ymthe.2019.05.012","journal-title":"Mol Ther"},{"key":"1441_CR188","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1016\/j.vaccine.2010.04.007","volume":"28","author":"AB Ryder","year":"2010","unstructured":"Ryder AB, Tollefson SJ, Podsiad AB, Johnson JE, Williams JV (2010) Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine 28:4145\u20134152. https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.007","journal-title":"Vaccine"},{"key":"1441_CR189","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7774\/cevr.2025.14.e12","volume":"14","author":"MI Saeed","year":"2025","unstructured":"Saeed MI (2025) Minireview: designing next generation human metapneumovirus (HMPV) vaccine. Clin Exp Vaccine Res 14:116\u2013118. https:\/\/doi.org\/10.7774\/cevr.2025.14.e12","journal-title":"Clin Exp Vaccine Res"},{"key":"1441_CR190","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1038\/sj.emboj.7601220","volume":"25","author":"SK Saha","year":"2006","unstructured":"Saha SK et al (2006) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25:3257\u20133263. https:\/\/doi.org\/10.1038\/sj.emboj.7601220","journal-title":"EMBO J"},{"key":"1441_CR191","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002613","author":"M Sarna","year":"2024","unstructured":"Sarna M et al (2024) Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care. BMJ Open Respir Res. https:\/\/doi.org\/10.1136\/bmjresp-2024-002613","journal-title":"BMJ Open Respir Res"},{"key":"1441_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2026.110798","volume":"617","author":"SK Saxena","year":"2026","unstructured":"Saxena SK et al (2026) Pathogenesis and current advancement in treatment and prevention strategies for human metapneumovirus. Virology 617:110798. https:\/\/doi.org\/10.1016\/j.virol.2026.110798","journal-title":"Virology"},{"key":"1441_CR193","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.1128\/jvi.79.16.10678-10689.2005","volume":"79","author":"JH Schickli","year":"2005","unstructured":"Schickli JH, Kaur J, Ulbrandt N, Spaete RR, Tang RS (2005) An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in Vero cells and does not alter tissue tropism in hamsters. J Virol 79:10678\u201310689. https:\/\/doi.org\/10.1128\/jvi.79.16.10678-10689.2005","journal-title":"J Virol"},{"key":"1441_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-5-69","volume":"5","author":"JH Schickli","year":"2008","unstructured":"Schickli JH, Kaur J, Macphail M, Guzzetta JM, Spaete RR, Tang RS (2008) Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters. Virol J 5:69. https:\/\/doi.org\/10.1186\/1743-422x-5-69","journal-title":"Virol J"},{"key":"1441_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00678","volume":"9","author":"ME Schmidt","year":"2018","unstructured":"Schmidt ME, Varga SM (2018) The CD8 T cell response to respiratory virus infections. Front Immunol 9:678. https:\/\/doi.org\/10.3389\/fimmu.2018.00678","journal-title":"Front Immunol"},{"key":"1441_CR196","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-064748","author":"S Schnyder Ghamloush","year":"2024","unstructured":"Schnyder Ghamloush S et al (2024) Safety and immunogenicity of an mRNA-based hMPV\/PIV3 combination vaccine in seropositive children. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2023-064748","journal-title":"Pediatrics"},{"key":"1441_CR197","doi-asserted-by":"publisher","first-page":"10931","DOI":"10.1128\/jvi.01287-06","volume":"80","author":"RM Schowalter","year":"2006","unstructured":"Schowalter RM, Smith SE, Dutch RE (2006) Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol 80:10931\u201310941. https:\/\/doi.org\/10.1128\/jvi.01287-06","journal-title":"J Virol"},{"key":"1441_CR198","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s15010-018-1194-5","volume":"47","author":"D Schreiner","year":"2019","unstructured":"Schreiner D et al (2019) High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics. Infection 47:201\u2013207. https:\/\/doi.org\/10.1007\/s15010-018-1194-5","journal-title":"Infection"},{"key":"1441_CR199","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/infdis\/jiu307","volume":"211","author":"JE Schuster","year":"2015","unstructured":"Schuster JE et al (2015) A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus. J Infect Dis 211:216\u2013225. https:\/\/doi.org\/10.1093\/infdis\/jiu307","journal-title":"J Infect Dis"},{"key":"1441_CR200","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.csbj.2025.02.011","volume":"27","author":"AM Sequeira","year":"2025","unstructured":"Sequeira AM, Rocha M, Lousa D (2025) Machine and deep learning to predict viral fusion peptides. Comput Struct Biotechnol J 27:692\u2013704. https:\/\/doi.org\/10.1016\/j.csbj.2025.02.011","journal-title":"Comput Struct Biotechnol J"},{"key":"1441_CR201","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cr.7310019","volume":"16","author":"RB Seth","year":"2006","unstructured":"Seth RB, Sun L, Chen ZJ (2006) Antiviral innate immunity pathways. Cell Res 16:141\u2013147. https:\/\/doi.org\/10.1038\/sj.cr.7310019","journal-title":"Cell Res"},{"key":"1441_CR202","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/14787210.2017.1279970","volume":"15","author":"L Shahani","year":"2017","unstructured":"Shahani L, Ariza-Heredia EJ, Chemaly RF (2017) Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti-Infect Ther 15:401\u2013415. https:\/\/doi.org\/10.1080\/14787210.2017.1279970","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1441_CR203","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1399-3062.2010.00575.x","volume":"13","author":"S Shahda","year":"2011","unstructured":"Shahda S, Carlos WG, Kiel PJ, Khan BA, Hage CA (2011) The human metapneumovirus: a case series and review of the literature. Transpl Infect Dis 13:324\u2013328. https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00575.x","journal-title":"Transpl Infect Dis"},{"key":"1441_CR204","doi-asserted-by":"publisher","first-page":"ofaf160","DOI":"10.1093\/ofid\/ofaf160","volume":"12","author":"C Shapiro","year":"2025","unstructured":"Shapiro C et al (2025) A randomized phase 1 clinical trial of a respiratory syncytial virus and human metapneumovirus combination Protein-Based virus-like particle vaccine in adults 60\u201375 years of age. Open Forum Infect Dis 12:ofaf160. https:\/\/doi.org\/10.1093\/ofid\/ofaf160","journal-title":"Open Forum Infect Dis"},{"key":"1441_CR205","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/imr.13118","volume":"309","author":"S Sheikh-Mohamed","year":"2022","unstructured":"Sheikh-Mohamed S, Sanders EC, Gommerman JL, Tal MC (2022) Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection. Immunol Rev 309:75\u201385. https:\/\/doi.org\/10.1111\/imr.13118","journal-title":"Immunol Rev"},{"key":"1441_CR206","doi-asserted-by":"crossref","unstructured":"Shrivastav A, Singh M, Vashishtha TK, Saxena R, Mishra AK, Verma N (2026) Human metapneumovirus (HMPV): epidemiology, pathogenesis, clinical Impact, and advances in diagnosis, treatment, and vaccine development. Biomedical Pharmacol J 19","DOI":"10.13005\/bpj\/3344"},{"key":"1441_CR207","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1128\/JVI.78.13.6927-6937.2004","volume":"78","author":"MH Skiadopoulos","year":"2004","unstructured":"Skiadopoulos MH et al (2004) The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 78:6927\u20136937","journal-title":"J Virol"},{"key":"1441_CR208","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.virol.2005.10.016","volume":"345","author":"MH Skiadopoulos","year":"2006","unstructured":"Skiadopoulos MH et al (2006) Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345:492\u2013501","journal-title":"Virology"},{"key":"1441_CR209","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3201\/eid1708.051239","volume":"12","author":"TP Sloots","year":"2006","unstructured":"Sloots TP et al (2006) Human metapneumovirus, Australia, 2001\u20132004. Emerg Infect Dis 12:1263\u20131266. https:\/\/doi.org\/10.3201\/eid1708.051239","journal-title":"Emerg Infect Dis"},{"key":"1441_CR210","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02466","volume":"9","author":"JA Soto","year":"2018","unstructured":"Soto JA et al (2018) Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system. Front Immunol 9:2466. https:\/\/doi.org\/10.3389\/fimmu.2018.02466","journal-title":"Front Immunol"},{"key":"1441_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-020-00162-6","volume":"26","author":"JA Soto","year":"2020","unstructured":"Soto JA, G\u00e1lvez NMS, Pacheco GA, Bueno SM, Kalergis AM (2020) Antibody development for preventing the human respiratory syncytial virus pathology. Mol Med 26:35. https:\/\/doi.org\/10.1186\/s10020-020-00162-6","journal-title":"Mol Med"},{"key":"1441_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9060481","author":"E Stepanova","year":"2020","unstructured":"Stepanova E, Matyushenko V, Rudenko L, Isakova-Sivak I (2020a) Prospects of and barriers to the development of epitope-based vaccines against human metapneumovirus. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9060481","journal-title":"Pathogens"},{"key":"1441_CR213","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9060481","author":"E Stepanova","year":"2020","unstructured":"Stepanova E, Matyushenko V, Rudenko L, Isakova-Sivak I (2020b) Prospects of and barriers to the development of epitope-based vaccines against human metapneumovirus. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9060481","journal-title":"Pathogens"},{"key":"1441_CR214","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.2174\/138161209789105171","volume":"15","author":"LJ Stern","year":"2009","unstructured":"Stern LJ, Calvo-Calle JM (2009) Hla-DR: molecular insights and vaccine design. Curr Pharm Des 15:3249\u20133261. https:\/\/doi.org\/10.2174\/138161209789105171","journal-title":"Curr Pharm Des"},{"key":"1441_CR215","doi-asserted-by":"publisher","first-page":"12265","DOI":"10.1073\/pnas.1811980115","volume":"115","author":"GBE Stewart-Jones","year":"2018","unstructured":"Stewart-Jones GBE et al (2018) Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1\u20134. Proc Natl Acad Sci U S A 115:12265\u201312270. https:\/\/doi.org\/10.1073\/pnas.1811980115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1441_CR216","doi-asserted-by":"publisher","unstructured":"Stewart-Jones GBE et al (2021) Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses. Proc Natl Acad Sci U S A 118. https:\/\/doi.org\/10.1073\/pnas.2106196118","DOI":"10.1073\/pnas.2106196118"},{"key":"1441_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104389","volume":"132","author":"M Tahir Ul Qamar","year":"2021","unstructured":"Tahir Ul Qamar M et al (2021) Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches. Comput Biol Med 132:104389. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104389","journal-title":"Comput Biol Med"},{"key":"1441_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intimm\/dxh186","volume":"17","author":"K Takeda","year":"2005","unstructured":"Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1\u201314. https:\/\/doi.org\/10.1093\/intimm\/dxh186","journal-title":"Int Immunol"},{"key":"1441_CR219","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/infdis\/jit356","volume":"208","author":"KR Talaat","year":"2013","unstructured":"Talaat KR et al (2013) Experimental infection of adults with recombinant wild-type human metapneumovirus. J Infect Dis 208:1669\u20131678. https:\/\/doi.org\/10.1093\/infdis\/jit356","journal-title":"J Infect Dis"},{"key":"1441_CR220","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4269\/ajtmh.2007.76.182","volume":"76","author":"GA Talavera","year":"2007","unstructured":"Talavera GA, M\u00e9zquita NE (2007) Human metapneumovirus in children with influenza-like illness in Yucatan, Mexico. Am J Trop Med Hyg 76:182\u2013183","journal-title":"Am J Trop Med Hyg"},{"key":"1441_CR221","first-page":"37","volume":"66","author":"C Tecu","year":"2007","unstructured":"Tecu C et al (2007) First detection of human metapneumovirus in children with respiratory infections in Romania. Roum Arch Microbiol Immunol 66:37\u201340","journal-title":"Roum Arch Microbiol Immunol"},{"key":"1441_CR222","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1016\/j.vaccine.2024.04.048","volume":"42","author":"B Trinit\u00e9","year":"2024","unstructured":"Trinit\u00e9 B et al (2024) VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice. Vaccine 42:3474\u20133485. https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.048","journal-title":"Vaccine"},{"key":"1441_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2025.111557","volume":"86","author":"F Ullah","year":"2025","unstructured":"Ullah F, Ullah S, Amin M, Ullah W, Ullah S, Wang S (2025) An in-silico design of a multi-epitope vaccine candidate against human metapneumovirus (HMPV) through prediction of B- and T-cell epitopes and molecular dynamics simlation. Hum Immunol 86:111557. https:\/\/doi.org\/10.1016\/j.humimm.2025.111557","journal-title":"Hum Immunol"},{"key":"1441_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022a.105405","volume":"207","author":"A Van Den Bergh","year":"2022","unstructured":"Van Den Bergh A, Bailly B, Guillon P, von Itzstein M, Dirr L (2022aa) Antiviral strategies against human metapneumovirus: targeting the fusion protein. Antiviral Res 207:105405. https:\/\/doi.org\/10.1016\/j.antiviral.2022a.105405","journal-title":"Antiviral Res"},{"key":"1441_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022b.105405","volume":"207","author":"A Van Den Bergh","year":"2022","unstructured":"Van Den Bergh A, Bailly B, Guillon P, von Itzstein M, Dirr L (2022bb) Antiviral strategies against human metapneumovirus: targeting the fusion protein. Antiviral Res 207:105405. https:\/\/doi.org\/10.1016\/j.antiviral.2022b.105405","journal-title":"Antiviral Res"},{"key":"1441_CR226","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01008-22","volume":"66","author":"A Van Den Bergh","year":"2022","unstructured":"Van Den Bergh A, Guillon P, von Itzstein M, Bailly B, Dirr L (2022c) Drug repurposing for therapeutic discovery against human metapneumovirus infection. Antimicrob Agents Chemother 66:e0100822. https:\/\/doi.org\/10.1128\/aac.01008-22","journal-title":"Antimicrob Agents Chemother"},{"key":"1441_CR227","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01008-22","volume":"66","author":"A Van Den Bergh","year":"2022","unstructured":"Van Den Bergh A, Guillon P, von Itzstein M, Bailly B, Dirr L (2022) Drug repurposing for therapeutic discovery against human metapneumovirus infection. Antimicrob Agents Chemother 66:e01008-01022. https:\/\/doi.org\/10.1128\/aac.01008-22","journal-title":"Antimicrob Agents Chemother"},{"key":"1441_CR228","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01641-23","volume":"98","author":"A Van Den Bergh","year":"2024","unstructured":"Van Den Bergh A, Bailly B, Guillon P, von Itzstein M, Dirr L (2024) Novel insights into the host cell glycan binding profile of human metapneumovirus. J Virol 98:e01641-01623","journal-title":"J Virol"},{"key":"1441_CR229","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1086\/513295","volume":"44","author":"BG van den Hoogen","year":"2007","unstructured":"van den Hoogen BG (2007) Respiratory tract infection due to human metapneumovirus among elderly patients. Clin Infect Dis 44:1159\u20131160. https:\/\/doi.org\/10.1086\/513295","journal-title":"Clin Infect Dis"},{"key":"1441_CR230","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/89098","volume":"7","author":"BG van den Hoogen","year":"2001","unstructured":"van den Hoogen BG et al (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719\u2013724. https:\/\/doi.org\/10.1038\/89098","journal-title":"Nat Med"},{"key":"1441_CR231","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/viro.2001.1355","volume":"295","author":"BG van den Hoogen","year":"2002","unstructured":"van den Hoogen BG, Bestebroer TM, Osterhaus AD, Fouchier RA (2002) Analysis of the genomic sequence of a human metapneumovirus. Virology 295:119\u2013132. https:\/\/doi.org\/10.1006\/viro.2001.1355","journal-title":"Virology"},{"key":"1441_CR232","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/viro.2001.1355","volume":"295","author":"BG van den Hoogen","year":"2002","unstructured":"van den Hoogen BG, Bestebroer TM, Osterhaus AD, Fouchier RA (2002b) Analysis of the genomic sequence of a human metapneumovirus. Virology 295:119\u2013132","journal-title":"Virology"},{"key":"1441_CR233","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1086\/379200","volume":"188","author":"BG van den Hoogen","year":"2003","unstructured":"van den Hoogen BG et al (2003) Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188:1571\u20131577. https:\/\/doi.org\/10.1086\/379200","journal-title":"J Infect Dis"},{"key":"1441_CR234","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3201\/eid1004.030393","volume":"10","author":"BG van den Hoogen","year":"2004","unstructured":"van den Hoogen BG et al (2004) Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10:658\u2013666. https:\/\/doi.org\/10.3201\/eid1004.030393","journal-title":"Emerg Infect Dis"},{"key":"1441_CR235","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1609615","volume":"13","author":"I Villanueva-Miranda","year":"2025","unstructured":"Villanueva-Miranda I, Xiao G, Xie Y (2025) Artificial intelligence in early warning systems for infectious disease surveillance: a systematic review. Front Public Health 13:1609615. https:\/\/doi.org\/10.3389\/fpubh.2025.1609615","journal-title":"Front Public Health"},{"key":"1441_CR236","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1086\/380907","volume":"189","author":"EE Walsh","year":"2004","unstructured":"Walsh EE, Peterson DR, Falsey AR (2004) Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 189:233\u2013238. https:\/\/doi.org\/10.1086\/380907","journal-title":"J Infect Dis"},{"key":"1441_CR237","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/s2214-109x(20)30393-4","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health 9:e33\u2013e43. https:\/\/doi.org\/10.1016\/s2214-109x(20)30393-4","journal-title":"Lancet Glob Health"},{"key":"1441_CR238","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10753-023-01911-5","volume":"47","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024a) SIRT6 protects against Lipopolysaccharide-Induced inflammation in human pulmonary lung microvascular endothelial cells. Inflammation 47:323\u2013332. https:\/\/doi.org\/10.1007\/s10753-023-01911-5","journal-title":"Inflammation"},{"key":"1441_CR239","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024b.24.e3","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang L, Yu Q, Xiao J, Chen Q, Fang M, Zhao H (2024bb) Cigarette smoke extract-treated mouse airway epithelial cells-derived exosomal LncRNA MEG3 promotes M1 macrophage polarization and pyroptosis in chronic obstructive pulmonary disease by upregulating TREM-1 via m(6)A methylation. Immune Netw 24:e3. https:\/\/doi.org\/10.4110\/in.2024b.24.e3","journal-title":"Immune Netw"},{"key":"1441_CR240","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03358-y","volume":"44","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025a) Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration. J Exp Clin Cancer Res 44:97. https:\/\/doi.org\/10.1186\/s13046-025-03358-y","journal-title":"J Exp Clin Cancer Res"},{"key":"1441_CR241","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bsheal.2025b.07.005","volume":"7","author":"X Wang","year":"2025","unstructured":"Wang X, Luo J, Cai X, Liu R, Li Y, Hon C (2025bb) DeepHVI: a multimodal deep learning framework for predicting human-virus protein-protein interactions using protein language models. Biosaf Health 7:257\u2013266. https:\/\/doi.org\/10.1016\/j.bsheal.2025b.07.005","journal-title":"Biosaf Health"},{"key":"1441_CR242","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1128\/jvi.03491-13","volume":"88","author":"Y Wei","year":"2014","unstructured":"Wei Y et al (2014) Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol 88:4338\u20134352. https:\/\/doi.org\/10.1128\/jvi.03491-13","journal-title":"J Virol"},{"key":"1441_CR243","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/cvi.00230-15","volume":"22","author":"SC Wen","year":"2015","unstructured":"Wen SC, Williams JV (2015) New approaches for immunization and therapy against human metapneumovirus. Clin Vaccine Immunol 22:858\u2013866. https:\/\/doi.org\/10.1128\/cvi.00230-15","journal-title":"Clin Vaccine Immunol"},{"key":"1441_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.272","volume":"2","author":"X Wen","year":"2017","unstructured":"Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE Jr., Jardetzky TS (2017) Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Nat Microbiol 2:16272. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.272","journal-title":"Nat Microbiol"},{"key":"1441_CR245","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.chom.2023.07.002","volume":"31","author":"X Wen","year":"2023","unstructured":"Wen X et al (2023a) Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode. Cell Host Microbe 31:1288-1300.e1286. https:\/\/doi.org\/10.1016\/j.chom.2023.07.002","journal-title":"Cell Host Microbe"},{"key":"1441_CR246","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.chom.2023.07.002","volume":"31","author":"X Wen","year":"2023","unstructured":"Wen X et al (2023b) Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode. Cell Host Microbe 31:1288-1300.e1286. https:\/\/doi.org\/10.1016\/j.chom.2023.07.002","journal-title":"Cell Host Microbe"},{"key":"1441_CR256","doi-asserted-by":"publisher","unstructured":"Wu L, Rizaev J, Fawy KF, kadham Mj, Dildora N, Kurbanova S, Atamuratova Z, Dauletbaev A, Lakshmaiya N, Al-Aouadi RFA (2026) The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials. Clin Transl Oncol. https:\/\/doi.org\/10.1007\/s12094-025-04175-7","DOI":"10.1007\/s12094-025-04175-7"},{"key":"1441_CR247","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0166-3542(03)00153-0","volume":"60","author":"PR Wyde","year":"2003","unstructured":"Wyde PR, Chetty SN, Jewell AM, Boivin G, Piedra PA (2003) Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 60:51\u201359. https:\/\/doi.org\/10.1016\/s0166-3542(03)00153-0","journal-title":"Antiviral Res"},{"key":"1441_CR248","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.antiviral.2004.02.006","volume":"63","author":"PR Wyde","year":"2004","unstructured":"Wyde PR, Moylett EH, Chetty SN, Jewell A, Bowlin TL, Piedra PA (2004) Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. Antiviral Res 63:51\u201359. https:\/\/doi.org\/10.1016\/j.antiviral.2004.02.006","journal-title":"Antiviral Res"},{"key":"1441_CR249","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00705-013-1622-x","volume":"158","author":"CF Yang","year":"2013","unstructured":"Yang CF et al (2013) Human metapneumovirus G protein is highly conserved within but not between genetic lineages. Arch Virol 158:1245\u20131252. https:\/\/doi.org\/10.1007\/s00705-013-1622-x","journal-title":"Arch Virol"},{"key":"1441_CR250","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013312","volume":"21","author":"A Young","year":"2025","unstructured":"Young A et al (2025) A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus. PLoS Pathog 21:e1013312. https:\/\/doi.org\/10.1371\/journal.ppat.1013312","journal-title":"PLoS Pathog"},{"key":"1441_CR257","doi-asserted-by":"crossref","unstructured":"Zafar N, Dilmurod U, Kadirov I, Gulbakhor E, Akmal S, Gulnora G, Rustam S, Karimbaevna TM, Usmanov R, Abduk\u0430dirova M, Ruzieva M, Khudoyarova G, Ishankulov A (2026) Urinary exosomes: emerging biomarkers for urinarytract infection. Clin Chim Acta 581:120757","DOI":"10.1016\/j.cca.2025.120757"},{"key":"1441_CR251","doi-asserted-by":"publisher","first-page":"112758","DOI":"10.1016\/j.microc.2025.112758","volume":"209","author":"H Zeng","year":"2025","unstructured":"Zeng H et al (2025) A signal enhanced lateral flow immunoassay based on core\u2013shell quantum Dots labeled antibody and antigen for sensitive detection of CP4-EPSPS protein. Microchem J 209:112758. https:\/\/doi.org\/10.1016\/j.microc.2025.112758","journal-title":"Microchem J"},{"key":"1441_CR252","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.1128\/jvi.00876-14","volume":"88","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J (2014) Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase. J Virol 88:11411\u201311429. https:\/\/doi.org\/10.1128\/jvi.00876-14","journal-title":"J Virol"},{"key":"1441_CR253","doi-asserted-by":"publisher","first-page":"2263229","DOI":"10.1080\/21645515.2023.2263229","volume":"19","author":"HQ Zhang","year":"2023","unstructured":"Zhang HQ, Cao BZ, Cao QT, Hun M, Cao L, Zhao MY (2023) An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination. Hum Vaccin Immunother 19:2263229. https:\/\/doi.org\/10.1080\/21645515.2023.2263229","journal-title":"Hum Vaccin Immunother"},{"key":"1441_CR254","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","volume":"44","author":"J Zhao","year":"2016","unstructured":"Zhao J et al (2016) Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44:1379\u20131391. https:\/\/doi.org\/10.1016\/j.immuni.2016.05.006","journal-title":"Immunity"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01441-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01441-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01441-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:40:34Z","timestamp":1793785234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01441-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":257,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1441"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01441-1","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}